Japan is one of the few countries in the world that has created new drugs, and while it possesses high potential for innovation, such as excellent basic research in academia and manufacturing technologies possessed by SMEs, it has been pointed out that it has not fully utilized its potential. In particular, ventures (medical ventures) that aim to commercialize pharmaceuticals, medical devices, regenerative medicine and other products are required to fully demonstrate their capabilities and to drive medical innovation in our country as in Europe and the United States.

The Ministry of Health, Labour and Welfare of Japan is working on measures to promote the practical application of excellent seeds discovered in academia, etc.. and establish a virtuous cycle (ecosystem) for nurturing medical ventures.

To further accelerate this process, we will hold the Japan Healthcare Venture Summit 2025 in Pacifico Yokohama, following on from last year. At the Summit, medical ventures will have booths and presentations to provide opportunities for matching and networking with key people from major companies, financial institutions, research institutions, etc., and to create an environment in which stakeholders can deepen their understanding of the current state of regulatory and related systems and venture support initiatives.

We hope that medical ventures and academia, which have seeds that are expected to lead to innovative pharmaceuticals, medical devices, regenerative medicine and other products, will participate in this Summit and that it will serve as a place to step up toward practical application.

Organizing Committee of Japan Healthcare Venture Summit

Name

Japan Healthcare Venture Summit 2025

Dates

Oct.8(wed)-10(fri), 2025

Venue

Pacifico Yokohama

Organizers

Ministry of Health, Labour and Welfare
(Office of Pharmaceutical Industry and Venture Support Policy Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau)

Co-located Events